Cargando…

FOXC1 identifies basal-like breast cancer in a hereditary breast cancer cohort

Breast cancers arising in the setting of the hereditary breast cancer genes BRCA1 and BRCA2 are most commonly classified as basal-like breast cancer (BLBC) or luminal breast cancer, respectively. BLBC is an aggressive subtype of breast cancer associated with liver and lung metastases and poorer prog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Johnson, Jeff, Choi, Michael, Dadmanesh, Farnaz, Han, Bingchen, Qu, Ying, Yu-Rice, Yi, Zhang, Xiao, Bagaria, Sanjay, Taylor, Clive, Giuliano, Armando E., Amersi, Farin, Cui, Xiaojiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342773/ https://www.ncbi.nlm.nih.gov/pubmed/27708239 http://dx.doi.org/10.18632/oncotarget.12370

Ejemplares similares

Identification of EGF-NF-κB-FOXC1 signaling axis in basal-like breast cancer
por: Chung, Stacey, et al.
Publicado: (2017)

FOXC1: an emerging marker and therapeutic target for cancer
por: Han, Bingchen, et al.
Publicado: (2017)

FOXC1-Induced Non-Canonical WNT5A-MMP7 Signaling Regulates Invasiveness in Triple-Negative Breast Cancer
por: Han, Bingchen, et al.
Publicado: (2017)

Inhibition of lobuloalveolar development by FOXC1 overexpression in the mouse mammary gland
por: Gao, Bowen, et al.
Publicado: (2017)

FOXC1 is involved in ERα silencing by counteracting GATA3 binding and is implicated in endocrine resistance
por: Yu-Rice, Yi, et al.
Publicado: (2016)

Breast cancer lung metastasis: Molecular biology and therapeutic implications
por: Jin, Liting, et al.
Publicado: (2018)

Characterization of primary human mammary epithelial cells isolated and propagated by conditional reprogrammed cell culture
por: Jin, Liting, et al.
Publicado: (2017)

De-Implementation of Low-Value Care for Women 70 Years of Age or Older with Low-Risk Breast Cancer During the COVID-19 Pandemic
por: Wang, Ton, et al.
Publicado: (2023)

Identification of triptonide as a therapeutic agent for triple negative breast cancer treatment
por: Gao, Bowen, et al.
Publicado: (2021)

Gene Expression Profiling of Fibroepithelial Lesions of the Breast
por: Li, Xiaomo, et al.
Publicado: (2023)

FOXC1 is associated with estrogen receptor alpha and affects sensitivity of tamoxifen treatment in breast cancer
por: Wang, Jinhua, et al.
Publicado: (2016)

FOXC1-induced LINC01123 acts as a mediator in triple negative breast cancer
por: Zhang, Purong, et al.
Publicado: (2020)

Pathology of hereditary breast cancer
por: van der Groep, Petra, et al.
Publicado: (2011)

Hereditary breast and ovarian cancer
por: Gronwald, Jacek, et al.
Publicado: (2008)

Management of Hereditary Breast Cancer
por: Eccles, D. M., et al.
Publicado: (1999)

The Pathology of Hereditary Breast Cancer
por: Lakhani, Sunil R.
Publicado: (1999)

The Pathology of Hereditary Breast Cancer
por: Honrado, Emiliano, et al.
Publicado: (2004)

Prophylaxis of hereditary breast cancer
por: de Groot, Jolien S., et al.
Publicado: (2017)

FOXC1, the new player in the cancer sandbox
por: Elian, Fahed A., et al.
Publicado: (2017)

The Diverse Consequences of FOXC1 Deregulation in Cancer
por: Gilding, L. Niall, et al.
Publicado: (2019)

Transcriptome and proteome characterization of surface ectoderm cells differentiated from human iPSCs
por: Qu, Ying, et al.
Publicado: (2016)

Promoting Clinical Breast Evaluations in a Lower Middle–Income Country Setting: An Approach Toward Achieving a Sustainable Breast Health Program
por: Buribekova, Roziya, et al.
Publicado: (2018)

Novel FOXC2 Mutation in Hereditary Distichiasis Impairs DNA-Binding Activity and Transcriptional Activation
por: Zhang, Leilei, et al.
Publicado: (2016)

Hereditary breast cancer in Northern Ireland.
por: McKinley, A. G., et al.
Publicado: (1996)

Pathology of Hereditary Breast and Ovarian Cancer
por: Hodgson, Anjelica, et al.
Publicado: (2020)

Surgical Management of Hereditary Breast Cancer
por: Berger, Elizabeth R., et al.
Publicado: (2021)

Breast cancer liver metastasis: Pathogenesis and clinical implications
por: Liu, Cuiwei, et al.
Publicado: (2022)

Current Status of Breast Organoid Models
por: Mohan, Srivarshini Cherukupalli, et al.
Publicado: (2021)

FOXC2 Promotes Vasculogenic Mimicry in Ovarian Cancer
por: Recouvreux, Maria Sol, et al.
Publicado: (2022)

Impact of OGT deregulation on EZH2 target genes FOXA1 and FOXC1 expression in breast cancer cells
por: Forma, Ewa, et al.
Publicado: (2018)

Long Noncoding RNA FOXC2-AS1 Predicts Poor Survival in Breast Cancer Patients and Promotes Cell Proliferation
por: Yang, Haisong, et al.
Publicado: (2019)

Incidence and prognostic impact of HER2‐positivity loss after dual HER2‐directed neoadjuvant therapy for HER2+ breast cancer
por: LeVee, Alexis, et al.
Publicado: (2023)

Biomarkers for Basal-like Breast Cancer
por: Choo, Jennifer R., et al.
Publicado: (2010)

Cancer stem cell heterogeneity in hereditary breast cancer
por: Wicha, Max S
Publicado: (2008)

Smaller Copper Oxide Nanoparticles have More Biological Effects Versus Breast Cancer and Nosocomial Infections Bacteria
por: Abbasi, Ardeshir, et al.
Publicado: (2021)

Hereditary Breast-Ovarian Cancer Syndrome in Russia
por: Sokolenko, A.P., et al.
Publicado: (2010)

Advocate's Viewpoint on Hereditary Breast/Ovarian Cancer
por: Kolling-Dandrieu, Francisca Bach
Publicado: (2004)

Hereditary Breast Cancer in the Han Chinese Population
por: Cao, Wenming, et al.
Publicado: (2013)

Gene expression signature of hereditary breast cancer
por: Dudaladava, V, et al.
Publicado: (2005)

Surgery and prophylactic surgery in hereditary breast cancer()
por: Morrow, Monica
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6di5tuv9fa80jpd8chhg4s8cgs